Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center

Hemasphere. 2021 Jun 28;5(7):e611. doi: 10.1097/HS9.0000000000000611. eCollection 2021 Jul.

Authors

Alesia Khan^{1

2}, Claire Woodley¹, Deepti Radia¹, George N Mikhaeel³, Jessica Brady³, Natalia Curto Garcia¹, Patrick Harrington¹, Jennifer O'Sullivan¹, Shahram Kordasti^{1

4}, Yvonne Francis¹, Susan Asirvatham¹, Sahra Ali¹, Priya Sriskandarajah¹, Jamie Saunders¹, Hugues de Lavallade¹, Donal P McLornan¹, Claire N Harrison¹

Affiliations

¹ Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
² Department of Haematology, St. James' Hospital, Leeds, United Kingdom.
³ Department of Clinical Oncology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
⁴ Comprehensive Cancer Centre, King's College London, London, United Kingdom.

No abstract available

Publication types

Case Reports